These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 34050011)

  • 1. Frequent loss of heterozygosity in CRISPR-Cas9-edited early human embryos.
    Alanis-Lobato G; Zohren J; McCarthy A; Fogarty NME; Kubikova N; Hardman E; Greco M; Wells D; Turner JMA; Niakan KK
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34050011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
    Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
    Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome editing reveals a role for OCT4 in human embryogenesis.
    Fogarty NME; McCarthy A; Snijders KE; Powell BE; Kubikova N; Blakeley P; Lea R; Elder K; Wamaitha SE; Kim D; Maciulyte V; Kleinjung J; Kim JS; Wells D; Vallier L; Bertero A; Turner JMA; Niakan KK
    Nature; 2017 Oct; 550(7674):67-73. PubMed ID: 28953884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas9 Editing Induces Loss of Heterozygosity in the Pathogenic Yeast Candida parapsilosis.
    Lombardi L; Bergin SA; Ryan A; Zuniga-Soto E; Butler G
    mSphere; 2022 Dec; 7(6):e0039322. PubMed ID: 36416551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele-specific genome editing using CRISPR-Cas9 is associated with loss of heterozygosity in diploid yeast.
    Gorter de Vries AR; Couwenberg LGF; van den Broek M; de la Torre Cortés P; Ter Horst J; Pronk JT; Daran JG
    Nucleic Acids Res; 2019 Feb; 47(3):1362-1372. PubMed ID: 30517747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of mutation rates, mosaicism and off target mutations when injecting Cas9 mRNA or protein for genome editing of bovine embryos.
    Hennig SL; Owen JR; Lin JC; Young AE; Ross PJ; Van Eenennaam AL; Murray JD
    Sci Rep; 2020 Dec; 10(1):22309. PubMed ID: 33339870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embryonic POU5F1 is Required for Expanded Bovine Blastocyst Formation.
    Daigneault BW; Rajput S; Smith GW; Ross PJ
    Sci Rep; 2018 May; 8(1):7753. PubMed ID: 29773834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 as tool for functional study of genes involved in preimplantation embryo development.
    Kwon J; Namgoong S; Kim NH
    PLoS One; 2015; 10(3):e0120501. PubMed ID: 25775469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allele-Specific Chromosome Removal after Cas9 Cleavage in Human Embryos.
    Zuccaro MV; Xu J; Mitchell C; Marin D; Zimmerman R; Rana B; Weinstein E; King RT; Palmerola KL; Smith ME; Tsang SH; Goland R; Jasin M; Lobo R; Treff N; Egli D
    Cell; 2020 Dec; 183(6):1650-1664.e15. PubMed ID: 33125898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosaicism in CRISPR/Cas9-mediated genome editing.
    Mehravar M; Shirazi A; Nazari M; Banan M
    Dev Biol; 2019 Jan; 445(2):156-162. PubMed ID: 30359560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retained chromosomal integrity following CRISPR-Cas9-based mutational correction in human embryos.
    Bekaert B; Boel A; De Witte L; Vandenberghe W; Popovic M; Stamatiadis P; Cosemans G; Tordeurs L; De Loore AM; Chuva de Sousa Lopes SM; De Sutter P; Stoop D; Coucke P; Menten B; Heindryckx B
    Mol Ther; 2023 Aug; 31(8):2326-2341. PubMed ID: 37376733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9-mediated genome editing in naïve human embryonic stem cells.
    Jacobs EZ; Warrier S; Volders PJ; D'haene E; Van Lombergen E; Vantomme L; Van der Jeught M; Heindryckx B; Menten B; Vergult S
    Sci Rep; 2017 Nov; 7(1):16650. PubMed ID: 29192200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes.
    Liang P; Xu Y; Zhang X; Ding C; Huang R; Zhang Z; Lv J; Xie X; Chen Y; Li Y; Sun Y; Bai Y; Songyang Z; Ma W; Zhou C; Huang J
    Protein Cell; 2015 May; 6(5):363-372. PubMed ID: 25894090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low incidence of SNVs and indels in trio genomes of Cas9-mediated multiplex edited sheep.
    Wang X; Liu J; Niu Y; Li Y; Zhou S; Li C; Ma B; Kou Q; Petersen B; Sonstegard T; Huang X; Jiang Y; Chen Y
    BMC Genomics; 2018 May; 19(1):397. PubMed ID: 29801435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR gene editing in human embryos wreaks chromosomal mayhem.
    Ledford H
    Nature; 2020 Jul; 583(7814):17-18. PubMed ID: 32606465
    [No Abstract]   [Full Text] [Related]  

  • 16. Whole genomic analysis reveals atypical non-homologous off-target large structural variants induced by CRISPR-Cas9-mediated genome editing.
    Tsai HH; Kao HJ; Kuo MW; Lin CH; Chang CM; Chen YY; Chen HH; Kwok PY; Yu AL; Yu J
    Nat Commun; 2023 Aug; 14(1):5183. PubMed ID: 37626063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gene editing efficiencies of CRISPR/Cas9 and TALEN for generation of MSTN knock-out cashmere goats.
    Zhang J; Liu J; Yang W; Cui M; Dai B; Dong Y; Yang J; Zhang X; Liu D; Liang H; Cang M
    Theriogenology; 2019 Jul; 132():1-11. PubMed ID: 30981084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas9 gene editing induced complex on-target outcomes in human cells.
    Wen W; Zhang XB
    Exp Hematol; 2022 Jun; 110():13-19. PubMed ID: 35304271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verification of CRISPR editing and finding transgenic inserts by Xdrop indirect sequence capture followed by short- and long-read sequencing.
    Blondal T; Gamba C; Møller Jagd L; Su L; Demirov D; Guo S; Johnston CM; Riising EM; Wu X; Mikkelsen MJ; Szabova L; Mouritzen P
    Methods; 2021 Jul; 191():68-77. PubMed ID: 33582298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas gene editing in the human germline.
    Bekaert B; Boel A; Cosemans G; De Witte L; Menten B; Heindryckx B
    Semin Cell Dev Biol; 2022 Nov; 131():93-107. PubMed ID: 35305903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.